MARK1 and hepatocellular carcinoma: Subsequently, both the CCK-8 and the plate cloning experiments showed that overexpression of POTEE could counteract the inhibitory impact of overexpression of MARK1 on sorafenib-resistant HCC cell proliferation capacity (Figure 5b and c).